Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$9.81 - $12.62 $27,477 - $35,348
-2,801 Reduced 18.77%
12,122 $136,000
Q2 2023

Aug 11, 2023

SELL
$8.08 - $10.37 $29,015 - $37,238
-3,591 Reduced 19.4%
14,923 $150,000
Q1 2023

May 10, 2023

SELL
$8.79 - $14.58 $21,122 - $35,035
-2,403 Reduced 11.49%
18,514 $174,000
Q4 2022

Feb 14, 2023

BUY
$11.49 - $13.65 $85,106 - $101,105
7,407 Added 54.83%
20,917 $255,000
Q3 2022

Nov 14, 2022

BUY
$12.41 - $32.42 $18,689 - $48,824
1,506 Added 12.55%
13,510 $168,000
Q2 2022

Aug 15, 2022

SELL
$19.63 - $26.62 $11,169 - $15,146
-569 Reduced 4.53%
12,004 $236,000
Q1 2022

May 16, 2022

SELL
$24.65 - $29.0 $153,175 - $180,206
-6,214 Reduced 33.08%
12,573 $328,000
Q4 2021

Feb 14, 2022

BUY
$27.74 - $34.09 $217,453 - $267,231
7,839 Added 71.6%
18,787 $533,000
Q3 2021

Nov 15, 2021

SELL
$29.2 - $36.72 $1.4 Million - $1.76 Million
-47,896 Reduced 81.39%
10,948 $349,000
Q2 2021

Aug 13, 2021

BUY
$28.76 - $35.98 $1.43 Million - $1.79 Million
49,766 Added 548.2%
58,844 $2.04 Million
Q1 2021

May 13, 2021

SELL
$27.85 - $34.49 $60,518 - $74,946
-2,173 Reduced 19.31%
9,078 $267,000
Q4 2020

Feb 16, 2021

SELL
$27.53 - $33.79 $60,208 - $73,898
-2,187 Reduced 16.27%
11,251 $345,000
Q3 2020

Nov 13, 2020

SELL
$21.1 - $29.13 $178,991 - $247,109
-8,483 Reduced 38.7%
13,438 $375,000
Q2 2020

Aug 14, 2020

BUY
$18.94 - $24.93 $415,183 - $546,490
21,921 New
21,921 $470,000
Q1 2020

Jun 02, 2020

SELL
$16.68 - $32.25 $219,625 - $424,635
-13,167 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$25.29 - $29.45 $17,323 - $20,173
685 Added 5.49%
13,167 $388,000
Q3 2019

Nov 14, 2019

SELL
$25.62 - $34.96 $23,442 - $31,988
-915 Reduced 6.83%
12,482 $332,000
Q2 2019

Aug 14, 2019

BUY
$31.11 - $34.79 $416,780 - $466,081
13,397 New
13,397 $453,000

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $6.63B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.